Literature DB >> 34914499

Pan-cancer single-cell landscape of tumor-infiltrating T cells.

Liangtao Zheng1, Shishang Qin2, Wen Si1, Anqiang Wang3, Baocai Xing4, Ranran Gao2, Xianwen Ren2, Li Wang2, Xiaojiang Wu3, Ji Zhang3, Nan Wu5, Ning Zhang6, Hong Zheng7, Hanqiang Ouyang8,9, Keyuan Chen8,9, Zhaode Bu3, Xueda Hu2,10, Jiafu Ji3,11, Zemin Zhang1,2.   

Abstract

T cells play a central role in cancer immunotherapy, but we lack systematic comparison of the heterogeneity and dynamics of tumor-infiltrating T cells across cancer types. We built a single-cell RNA-sequencing pan-cancer atlas of T cells for 316 donors across 21 cancer types and revealed distinct T cell composition patterns. We found multiple state-transition paths in the exhaustion of CD8+ T cells and the preference of those paths among different tumor types. Certain T cell populations showed specific correlation with patient properties such as mutation burden, shedding light on the possible determinants of the tumor microenvironment. T cell compositions within tumors alone could classify cancer patients into groups with clinical trait specificity, providing new insights into T cell immunity and precision immunotherapy targeting T cells.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 34914499     DOI: 10.1126/science.abe6474

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   63.714


  38 in total

Review 1.  TCR-sequencing in cancer and autoimmunity: barcodes and beyond.

Authors:  Kristen E Pauken; Kaitlyn A Lagattuta; Benjamin Y Lu; Liliana E Lucca; Adil I Daud; David A Hafler; Harriet M Kluger; Soumya Raychaudhuri; Arlene H Sharpe
Journal:  Trends Immunol       Date:  2022-01-25       Impact factor: 16.687

2.  Single-cell meta-analyses reveal responses of tumor-reactive CXCL13+ T cells to immune-checkpoint blockade.

Authors:  Baolin Liu; Yuanyuan Zhang; Dongfang Wang; Xueda Hu; Zemin Zhang
Journal:  Nat Cancer       Date:  2022-09-22

3.  Innate-like T cells: A promising asset in anti-cancer immunity.

Authors:  Martina Molgora; Marco Colonna
Journal:  Cancer Cell       Date:  2022-06-16       Impact factor: 38.585

Review 4.  Next-generation sequencing: unraveling genetic mechanisms that shape cancer immunotherapy efficacy.

Authors:  Ahmed Halima; Winston Vuong; Timothy A Chan
Journal:  J Clin Invest       Date:  2022-06-15       Impact factor: 19.456

5.  Integrative immune transcriptomic classification improves patient selection for precision immunotherapy in advanced gastro-oesophageal adenocarcinoma.

Authors:  Manuel Cabeza-Segura; Valentina Gambardella; Francisco Gimeno-Valiente; Juan Antonio Carbonell-Asins; Lorena Alarcón-Molero; Arturo González-Vilanova; Sheila Zuñiga-Trejos; Pilar Rentero-Garrido; Rosana Villagrasa; Mireia Gil; Ana Durá; Paula Richart; Noelia Alonso; Marisol Huerta; Susana Roselló; Desamparados Roda; Noelia Tarazona; Carolina Martínez-Ciarpaglini; Josefa Castillo; Andrés Cervantes; Tania Fleitas
Journal:  Br J Cancer       Date:  2022-10-17       Impact factor: 9.075

6.  Shared and distinct biological circuits in effector, memory and exhausted CD8+ T cells revealed by temporal single-cell transcriptomics and epigenetics.

Authors:  Josephine R Giles; Shin Foong Ngiow; Sasikanth Manne; Amy E Baxter; Omar Khan; Ping Wang; Ryan Staupe; Mohamed S Abdel-Hakeem; Hua Huang; Divij Mathew; Mark M Painter; Jennifer E Wu; Yinghui Jane Huang; Rishi R Goel; Patrick K Yan; Giorgos C Karakousis; Xiaowei Xu; Tara C Mitchell; Alexander C Huang; E John Wherry
Journal:  Nat Immunol       Date:  2022-10-21       Impact factor: 31.250

7.  Neoadjuvant PD-1 blockade plus chemotherapy induces a high pathological complete response rate and anti-tumor immune subsets in clinical stage III gastric cancer.

Authors:  Xiaohuan Tang; Mengyuan Li; Xiaolong Wu; Ting Guo; Li Zhang; Lei Tang; Fangzhou Jia; Ying Hu; Yan Zhang; Xiaofang Xing; Fei Shan; Xiangyu Gao; Ziyu Li
Journal:  Oncoimmunology       Date:  2022-10-14       Impact factor: 7.723

8.  Programme of self-reactive innate-like T cell-mediated cancer immunity.

Authors:  Chun Chou; Xian Zhang; Chirag Krishna; Briana G Nixon; Saida Dadi; Kristelle J Capistrano; Emily R Kansler; Miranda Steele; Jian Han; Amy Shyu; Jing Zhang; Efstathios G Stamatiades; Ming Liu; Shun Li; Mytrang H Do; Chaucie Edwards; Davina S Kang; Chin-Tung Chen; Iris H Wei; Emmanouil P Pappou; Martin R Weiser; J Garcia-Aguilar; J Joshua Smith; Christina S Leslie; Ming O Li
Journal:  Nature       Date:  2022-04-20       Impact factor: 69.504

9.  The clinical significance of circulating tumor cells and T lymphocyte subtypes in pancreatic cancer patients.

Authors:  Yasi Xing; Xinfa Zhang; Fangyuan Qin; Jingwen Yang; Lei Ai; Qingsong Wang; Yaping Zhai
Journal:  Bioengineered       Date:  2022-02       Impact factor: 3.269

10.  Reprogramming and redifferentiation of mucosal-associated invariant T cells reveal tumor inhibitory activity.

Authors:  Chie Sugimoto; Yukie Murakami; Eisuke Ishii; Hiroyoshi Fujita; Hiroshi Wakao
Journal:  Elife       Date:  2022-04-05       Impact factor: 8.713

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.